Orthocell Ltd
Orthocell Ltd (ASX:OCC) is listed on the Australian Securities Exchange.
Related news
- Orthocell granted key US divisional patent for CelGro®
2021-02-15 - Orthocell shares sharply higher on back of positive results in CelGro® nerve repair clinical study
2020-11-20 - Orthocell submits Australian TGA regulatory application for CelGro® nerve regeneration platform
2020-07-30 - Orthocell's Ortho-ATI™ cell therapy features in respected ISAKOS textbook
2020-05-15 - Orthocell completes US 510(k) submission to FDA for CelGro® bone regeneration product
2020-05-12 - Orthocell secures European patent for its tissue regeneration technology
2018-05-25
